Athenex to acquire Kuur Therapeutics for $185m
Kuur’s NKT cell platform technology will help Athenex to expand its cell therapy development capabilities
Swiss firm Roivant Sciences to go public in $7.3bn deal
04 May 21The transaction will enable Roivant Sciences to become a public entity and is expected to be listed on…
Pfizer acquires antifungal therapies developer Amplyx
29 Apr 21The acquisition follows Pfizer’s initial equity investment in Amplyx, as part of the antifungal therapies developer's Series C…
AstraZeneca gets US FTC nod for $39bn Alexion acquisition
19 Apr 21AstraZeneca has initially announced the acquisition of the US-based pharmaceutical firm for a total consideration of $39bn in…
Thermo Fisher to acquire clinical research firm PPD for $17.4bn
16 Apr 21The business combination would add highly complementary services that further enhance Thermo Fisher’s value proposition for pharma and…
Sanofi acquires mRNA-based technology firm Tidal Therapeutics
12 Apr 21With the acquisition, Sanofi is expected to benefit from a new technology platform that expands its research capabilities…
Hologic to acquire molecular diagnostics firm Mobidiag for $795m
09 Apr 21The acquisition of Mobidiag will strengthen Hologic’s international and diagnostics businesses
Piramal to acquire peptide APIs manufacturer Hemmo for $105m
01 Apr 21With the acquisition, Piramal will benefit from Hemmo’s peptide API development and manufacturing capabilities
Amgen to acquire small-molecule therapies developer Rodeo
31 Mar 21Rodeo’s preclinical programme targeting 15-PGDH will support Amgen in developing therapeutic agents against inflammatory disease indications
AbbVie in talks to divest portfolio of women’s drugs worth $5bn
17 Mar 21AbbVie has acquired the portfolio of women's drugs as part of its $63bn acquisition of Allergan, completed last…